Compounds > substance p
Page last updated: 2024-08-23

substance p and Cancer of Ovary

substance p has been researched along with Cancer of Ovary in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19904 (44.44)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Afshari, AR; AlAlikhan, A; Ghahremanloo, A; Hashemy, SI; Javid, H; Momen Razmgah, M1
AlAlikhan, A; Ebrahimi, S; Ghahremanloo, A; Hashemy, SI; Javid, H1
Barr, J; Bell, M; Drapkin, R; Eichwald, T; Fettig, RR; Hooper, JE; Jung, E; Kovács, A; Lucido, CT; Muirhead, DM; Omran, DK; Reavis, H; Restaino, AC; Schwartz, LE; Spanos, WC; Talbot, S; Vermeer, DW; Vermeer, PD; Vermeer, SJ; Walz, A; Williamson, CS1
Goromaru, T; Hirakawa, T; Ishida, M; Itoh, Y; Nakano, H; Oishi, R; Sendo, T1
Cannon, D; Dervan, P; Powell, D; Skrabanek, P1
Eckhauser, FE; Jaffe, BM; Strodel, WE; Thompson, NW; Vinik, AI1
Everard, MJ; Macaulay, VM; Miller, JL; Smith, IE1
Chayvialle, JA; Dupire, E; Fontaine, P; Lecomte-Houcke, M; Lefebvre, J; Lemaire, C; Proye, C; Racadot-Leroy, N; Verin, P1
Goetzl, EJ; Longo, DL; Schiogolev, SA; Urba, WJ1

Reviews

1 review(s) available for substance p and Cancer of Ovary

ArticleYear
[Primary ovarian carcinoid with secretion of human pancreatic polypeptide and immunoreactivity to substance P].
    Chirurgie; memoires de l'Academie de chirurgie, 1988, Volume: 114, Issue:3

    Topics: Adult; Carcinoid Tumor; Female; Humans; Ovarian Neoplasms; Pancreatic Polypeptide; Substance P

1988

Other Studies

8 other study(ies) available for substance p and Cancer of Ovary

ArticleYear
The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.
    Molecular biology reports, 2022, Volume: 49, Issue:10

    Topics: Aprepitant; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Ovarian Neoplasms; Receptors, Neurokinin-1; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Substance P; Vascular Endothelial Growth Factor A

2022
The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells.
    Cell biochemistry and biophysics, 2022, Volume: 80, Issue:4

    Topics: Apoptosis; Aprepitant; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Female; Humans; NF-kappa B; Ovarian Neoplasms; Reactive Oxygen Species; Receptors, Neurokinin-1; Substance P; Tumor Suppressor Protein p53

2022
Functional neuronal circuits promote disease progression in cancer.
    Science advances, 2023, 05-10, Volume: 9, Issue:19

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Human Papillomavirus Viruses; Humans; Mice; Mice, Inbred C57BL; Neurons; Ovarian Neoplasms; Ovary; Specific Pathogen-Free Organisms; Squamous Cell Carcinoma of Head and Neck; Substance P; Survival Analysis

2023
Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent.
    Peptides, 2004, Volume: 25, Issue:7

    Topics: Animals; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Female; Histamine; Humans; Hypersensitivity; Indoles; Male; Neurokinin-1 Receptor Antagonists; Ovarian Neoplasms; Paclitaxel; Piperidines; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Retrospective Studies; Substance P

2004
Substance P in ovarian carcinoid.
    Journal of clinical pathology, 1980, Volume: 33, Issue:2

    Topics: Adult; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Substance P

1980
Substance P in the localization of a carcinoid tumor.
    Journal of surgical oncology, 1984, Volume: 27, Issue:2

    Topics: Carcinoid Tumor; Female; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Serotonin; Substance P; Veins

1984
In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.
    British journal of cancer, 1992, Volume: 65, Issue:3

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Bone Marrow; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Cell Line; Colony-Forming Units Assay; DNA; Dose-Response Relationship, Drug; Female; Fibroblasts; Humans; In Vitro Techniques; Insulin-Like Growth Factor I; Lung Neoplasms; Ovarian Neoplasms; Substance P; Time Factors; Vasopressins

1992
Appearance of neuropeptides in ascitic fluid after peritoneal therapy with interleukin-2 and lymphokine-activated killer cells for intraabdominal malignancy.
    Journal of clinical immunology, 1989, Volume: 9, Issue:2

    Topics: Ascitic Fluid; Calcitonin Gene-Related Peptide; Colonic Neoplasms; Female; Humans; Interleukin-2; Killer Cells, Natural; Neuropeptides; Ovarian Neoplasms; Recombinant Proteins; Substance P; Uterine Neoplasms

1989